DePalma R G, Clowes A W
Surgery. 1978 Aug;84(2):175-89.
For the surgeon, atherosclerosis is defined by a variety of aneurysmal, occlusive, or ulcerated lesions in major arteries. These end-stage lesions often require operative treatment. However, just as advanced atherosclerosis presents complex clinical phenomena, so its earlier stages display many underlying mechanisms promoting lesions. To arrest or control atherosclerosis, the disease must be approached with knowledge about diverse biological processes. These include ceullar and systemic aspects of lipoprotein metabolism, reactions and metabolism of endothelium and smooth muscle cells of the arterial wall, and interaction of platelets with the arterial intima. The chronic nature of this process is such that surgeons are involved intimately with overall management as well as with surgical procedures. We will review underlying biological processes of atherosclerosis as related to interventions in patients with clinically apparent disease.
对外科医生而言,动脉粥样硬化的定义是主要动脉中出现的各种动脉瘤样、闭塞性或溃疡性病变。这些终末期病变常常需要手术治疗。然而,正如晚期动脉粥样硬化呈现出复杂的临床现象一样,其早期阶段也显示出许多促进病变的潜在机制。要阻止或控制动脉粥样硬化,必须了解各种生物学过程才能应对这种疾病。这些过程包括脂蛋白代谢的细胞和全身方面、动脉壁内皮细胞和平滑肌细胞的反应及代谢,以及血小板与动脉内膜的相互作用。该过程具有慢性特点,这使得外科医生不仅要密切参与手术操作,还要全面参与整体管理。我们将回顾与对有明显临床症状患者的干预措施相关的动脉粥样硬化潜在生物学过程。